Company: STAA
Filing Date: 2025-10-08
Form Type: DFAN14A
Source: 0001213900-25-097463
Chunk: 7

Company: STAAR SURGICAL CO
Filing Date: 2025-10-08
Form: DFAN14A
Chunk 7
---
 and potentially scale-tipping rights afforded to the existing acquiror…    
 While a sufficiently interested buyer could indeed still approach STAAR despite the foregoing overhang, it would be disingenuous to    
 suggest these considerations are not pointedly evident deterrents when contrasted with an unencumbered pre-announcement market check.” |

The Wrong Price

| ● | “…[O]n a forward-looking basis,                                                                                              
 the deal appears to track below sector buyout trends and toward an evident near-term trough in STAAR’s historical valuation, 
 neither of which suggests the current offer should be considered decisively attractive.”                                     |

| ● | “On a forward-looking basis – an                                                                                                      
 approach we consider more relevant here, given STAAR’s trailing dynamics and projected recovery – we see the current terms            
 imply an NTM revenue multiple of approximately 4.56x. Viewed against [precedent healthcare equipment and supplies transactions], that 
 multiple would fall at the 34th percentile, below both the median (5.1x) and mean (6.2x) NTM revenue multiples implied by those       
 transactions.”                                                                                                                        |

| ● | “STAAR’s unaffected three- and five-year                                                                                                   
 average NTM multiples of 5.6x and 10.7x, respectively, track well above the deal multiple, further stressing that the proposed transaction 
 rests on a relatively recent trading nadir pegged to interim operational dislocation.”                                                     |

Broadwood encourages its fellow shareholders to
review its presentation, its proxy materials, and its press releases, all of which are available at www.LetSTAARShine.com.

About Broadwood

Broadwood Partners, L.P. is managed by Broadwood
Capital, Inc. Broadwood Capital is a private investment firm based in New York City. Neal C. Bradsher is the President of Broadwood Capital.

Certain Information Concerning the Participants

Broadwood Partners, L.P., Broadwood Capital, Inc.,
Neal C. Bradsher, Richard T. LeBuhn, Natalie R. Capasso, Raymond A. Myers and Jason J. Martin (collectively, the “Participants”)
are participants in the solicitation of proxies from the shareholders of STAAR in connection with the special meeting of shareholders
scheduled for October 23, 2025 (including any adjournments, postponements, reschedulings or continuations thereof, the “Special
Meeting”). The Participants have filed a definitive proxy statement on Schedule 14A (the “